• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Malaysian doctors back 2-D ultrasound

Article

Ultrasound specialists and obstetricians in Malaysia are complaining that the publicity surrounding three-dimensional ultrasound implies that two-dimensional technology is obsolete, “engendering tremendous anxiety among both patients and

Ultrasound specialists and obstetricians in Malaysia are complaining that the publicity surrounding three-dimensional ultrasound implies that two-dimensional technology is obsolete, “engendering tremendous anxiety among both patients and doctors,” according to an article in the New Straits Times.

These physicians point out that development in recent years of high-resolution 2-D probes and color Doppler ultrasound has enabled doctors to obtain images of the fetus with better clarity. Consequently, doctors are able to diagnose fetal abnormalities earlier in the pregnancy with greater confidence.

“Conventional 2-D ultrasound remains the primary method for detection of fetal abnormalities,” said Dr. Ravi Chandran, president of the Malaysian Society of Ultrasound in Medicine. “Three-D ultrasound is a developing technology and has yet to be shown to be superior to 2-D ultrasound in this respect.”

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.